BREAKTHROUGH: British Company Develops Cheaper, Effective COVID-19 Vaccine

( British-Swedish pharmaceutical company AstraZeneca announced on Monday that their late-stage trials show their COVID-19 vaccine is effective and likely cheaper than the vaccines already announced n the United States. Incredibly, the vaccine is also reportedly easier to store and could be the ideal option for distribution across the developing world.

The company said that their results came from an interim analysis of trials that took place in Brazil and the United Kingdom. The vaccine was developed by the University of Oxford and manufactured by the pharmaceutical company, and the trials reported zero severe cases or hospitalizations for anybody that received it.

It is the third major drug company to report positive late-stage data for their vaccine, and perhaps the most intriguing element of this option is that it does not need to be stored at freezing temperatures. It makes it easier to distribute the vaccine longer distances and ideal for developing countries where freezers may not be available and temperatures typically higher.

Dr. Andrew Pollard, the chief investigator of the trial, said that they are “exciting results.”

“Because the vaccine can be stored at fridge temperatures, it can be distributed around the world using the normal immunization distribution system,” he added. “And so our goal…to make sure that we have a vaccine that was accessible everywhere, I think we’ve actually managed to do that.”

The news comes as Dr. Moncef Slaoui, the chief scientific adviser for President Trump’s “Operation Warp Speed,” said that the Food and Drug Administration is expected to grant approval for the new vaccine in mid-December. It would mean that the vaccine produced by German company BioNTech and Pfizer Inc would begin to roll out before the end of the year.

“Within 24 hours from the approval, the vaccine will be moving and located in the areas where each state will have told us where they want the vaccine doses,” Slaou said on NBC.

“So I would expect maybe on day two after approval on the 11th or 12th of December, hopefully the first people will be immunized across the United States,” he also said on CNN.

President Donald Trump’s Operation Warp Speed helped developed and distribute a vaccine quicker than anyone expected, and the United States main ally the United Kingdom is right behind with a third vaccine that is perfect for distributing across the developing world.

What exactly does Joe Biden think the US government did wrong here?